EBS(Excelsior Bio‑System) Joins 9th Healthcare+ Expo Taiwan

Strengthening Global Links. Expanding Growth Opportunities.

Excelsior Bio‑System (EBS) recently participated in the B2B networking event hosted by the 9th Healthcare+ Expo Taiwan International Linkage Pavilion. EBS engaged with international market experts to explore cross‑border partnerships and accelerate the company’s global development strategy.
 
As a leading biomed company, EBS is committed to advancing allergy diagnostics and immune‑health management for both humans and animals. The company specializes in high‑precision, chip‑based allergen screening testing under its human healthcare brand AllerDot® and pet/animal health brand AllerSpot® (ebs.com.tw).

Why EBS Allergen Screening Testing Matters

Comprehensive Allergen Coverage —

EBS’s allergen screening panels cover a broad range of common environmental and food allergens, enabling detection of both acute (IgE‑mediated) allergies and chronic (IgG‑mediated) sensitivities.

Advanced Technology, Minimal Sample Required —

Utilizing microarray chip technology, EBS can analyze over 100 allergens with only ~1 cc of blood, significantly reducing the burden on test‑takers compared to traditional methods.

Personalized Immune & Health Management —

Test results help individuals and clinicians identify potential triggers, enabling tailored dietary or environmental adjustments and more effective allergy management.

Outcomes from the Expo Interaction

During the B2B sessions, EBS gained valuable insights into global demand for immunodiagnostics and allergy management. The AllerDot® / AllerSpot® platforms attracted strong interest from multiple overseas medical and veterinary stakeholders, potentially opening pathways for international collaboration, distribution, and joint market development.

EBS will continue to advance its core technologies, expanding clinical applications, strengthening international partnerships, and delivering precise immune‑health solutions. Through these efforts, EBS aims to bring Taiwanese biomedical innovation to global markets, enabling more people and pets worldwide to benefit from accurate allergen screening and improved health management.

EU biomedical experts presenting industry trends at the 9th Healthcare+ Expo Taiwan opening ceremony.

EBS Healthcare B2B session with Myanmar healthcare expert Aye Aye San presenting local medical market opportunities.

EBS international business and R&D team with Malaysian guests after sharing allergen screening testing success and market strategies.

BS team with Argentine medical device importers after discussing market development opportunities.